Qiagen Stock - Friday review and sector comparison
Published on 06/19/2026 at 16:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 16:39 CET. Details in the imprint.
Qiagen (NL0012169213) remains without new market-moving news today. The stock instead takes its cues from analyst consensus, peer-group performance and the broader diagnostics and life-science tools sector, according to current market data.
All news and analysis on Qiagen stock
Key background on Qiagen, current price data and previous headlines are bundled in the dedicated topic area on ad-hoc-news.de.
What the week shows
Qiagen stock trades in New York under the ticker QGEN and closed at $37.00 on 06/18/2026, according to MarketBeat data referencing the New York Stock Exchange quote.
That closing level implies a modest weekly performance in a market where many diagnostics and life-science tools peers also moved in a narrow band, with no major idiosyncratic catalyst for Qiagen identified by leading newswires.
How peers have fared
In the same sector, large US-listed comparables such as Thermo Fisher Scientific and Danaher have recently been trading on mid- to high-teens forward earnings multiples, reflecting solid but not exuberant expectations for demand in diagnostics and research consumables.
Qiagen’s valuation is typically benchmarked against this peer group by investors, who look at growth rates in molecular diagnostics and sample preparation to gauge whether the stock deserves a premium or discount to larger diversified players.
What the company sells
Qiagen generates most of its revenue with molecular testing solutions, including its flagship QIAamp sample preparation kits and QIAstat-Dx syndromic testing platforms for clinical laboratories and research customers worldwide.
Where the stock trades today
The shares of Qiagen (NL0012169213) trade on the New York Stock Exchange at $37.00 as of 06/18/2026, 15:59 ET.
Key facts on Qiagen stock
- Company: QIAGEN N.V.
- ISIN: NL0012169213
- WKN: A2DKCH
- Ticker: QGEN
- Venue: NYSE
- Price (as of 06/18/2026, 15:59 ET): 37.00 USD
- Market cap: 8,000,000,000 USD (as of 06/18/2026)
- Sector / Industry: Health Care / Life Sciences Tools & Services
- Index membership: Not a member of the S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
